Teclistamab is effective in real-world patients with R/RMM, including those with prior anti-BCMA Rx exposure, albeit with slightly poorer PFS; CD8 effector T cells enhance teclistamab response Ross Firestone Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Blood Advances #mmsm #bmtsm ashpublications.org/bloodadvances/…

Multiple myeloma patients previously treated with T-cell redirection therapy have significantly low risk of developing CRS with teclistamab #mmsm #bmtsm Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Blood Advances ashpublications.org/bloodadvances/…

Study S2213 is for people with newly diagnosed #ALAmyloidosis . It compares a combination of immunotherapy and chemo drugs (called Dara-VCD) to stem cell transplant. Learn more at SWOG.org/S2213. Or call 1-800-4-CANCER. Ask about S2213. #raredisease

CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma aacrjournals.org/cancerdiscover… MD Anderson Cancer Center

Yuval Noah Harari argues that AI has hacked the operating system of human civilisation economist.com/by-invitation/…

“Our study not only provides a proof of concept, but also opens the door for us and other investigators to improve these outcomes,” says our Dr. Samer Srour of a novel allogeneic CAR T cell therapy for  #KidneyCancer .

Learn about this research: bit.ly/4aJrLVh #AACR24 …

How a psychologist transformed economics: Daniel Kahneman was a master of teasing questions economist.com/finance-and-ec…

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. N= 2497. No difference in PFS or OS #mmsm Fieke Hoff Gurbakhash Kaur Rahul Banerjee, MD, FACP Blood Cancer Journal nature.com/articles/s4140…

Soluble BCMA in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma #mmsm Johannes Waldschmidt haematologica.org/article/view/h…

CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy #mmsm #bmtsm Sandy Wong Tom Martin Nina Shah Blood Advances ashpublications.org/bloodadvances/…

IL-18-secreting multi-antigen (BCMA and BAFF-R) targeting CAR T-cells eliminate antigen-low myeloma in an immunocompetent mouse model #mmsm #bmtsm Marcel van den Brink Blood Journal ashpublications.org/blood/article-…

Of all my tweets on taking care of patients, here are 3 personal favorites. #MedTwitter

1)

Could weight-loss drugs eat the world? economist.com/science-and-te… from The Economist

BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: efficacy, safety, and resistance mechanisms #mmsm #bmtsm nizar jacques bahlis Blood Journal sciencedirect.com/science/articl…

Anthony Epstein (1921–2024), discoverer of virus (EBV) causing cancer in humans nature.com/articles/d4158…